N-METHYL INDAZOLE-3-CARBOXYLIC ACID 50890-83-0 98%

Aion Research Center(ARC) Established in the year 2017, with Research & Development as its prime fundamental, Aion Research Center(ARC) focused on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry. With three years of experience, expertise and a proven track-record of helping many companies with its turn-key and consulting strengths. Company continually strives to comply to the current Good Manufacturing Practices (cGMP) guidelines. Aion Research Center(ARC) also undertakes NCE (New Chemical Entities), FTE/Contract Research on process development for discovering new compounds and non-infringing routes for leading MNCs across the world and partners with them for the supply of APIs. The company is global in its outlook and benchmarks its quality standards to the best in the world and constantly reviews and updates the same from time to time.